Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Volume 61, Number 1, July 08, 2003
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilman, S.
Right arrow Articles by Heumann, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilman, S.
Right arrow Articles by Heumann, M.
Related Collections
Right arrow Multiple system atrophy
Right arrow All Sleep Disorders
Right arrow Sleep apnea

Neurology 2003;61:35-39
© 2003 American Academy of Neurology

Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA

S. Gilman, MD FRCP, R. D. Chervin, MD, R. A. Koeppe, PhD, F.B. Consens, MD, R. Little, PhD, H. An, MS, L. Junck, MD and M. Heumann, BA

From the Department of Neurology (Drs. Gilman, Chervin, Consens, and Junck, M. Heumann); Division of Nuclear Medicine (Dr. Koeppe), Department of Radiology; and Department of Biostatistics(Dr. Little, H. An); University of Michigan, Ann Arbor.

Address correspondence and reprint requests to Dr. S. Gilman, Department of Neurology, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-0316; e-mail: sgilman{at}umich.edu

Objective: To explore the neurochemical basis of obstructive sleep apnea (OSA) in multiple-system atrophy (MSA).

Methods: In 13 patients with probable MSA, nocturnal, laboratory-based polysomnography was used to rate the severity of OSA using the apnea–hypopnea index during sleep. SPECT with (-)-5-[123I]iodobenzovesamicol ([123I]IBVM) was utilized to measure the density of thalamic cholinergic terminals, which project from the brainstem pedunculopontine and laterodorsal tegmental nuclei. PET with (+)-[11C]dihydrotetrabenazine ([11C]DTBZ) was also used to measure the density of striatal monoaminergic terminals, which project from the brainstem. Findings in the patient group were compared with data from 12 normal control subjects scanned utilizing [123I]IBVM and 15 normal control subjects utilizing [11C]DTBZ.

Results: Age and gender distributions were similar in patient and control groups. The MSA subjects showed decreased [123I]IBVM binding in the thalamus (p < 0.001) and decreased mean [11C]DTBZ binding in the striatum (p < 0.0001) in comparison with the control subjects. In the MSA group, thalamic [123I]IBVM binding was inversely correlated with the severity of OSA (p = 0.011). Striatal [11C]DTBZ binding was not correlated with the severity of OSA (p = 0.19).

Conclusion: Decreased pontine cholinergic projections may contribute to OSA in MSA.




This article has been cited by other articles:


Home page
ChestHome page
W. Moraes, D. Poyares, L. Sukys-Claudino, C. Guilleminault, and S. Tufik
Donepezil Improves Obstructive Sleep Apnea in Alzheimer Disease: A Double-Blind, Placebo-Controlled Study
Chest, March 1, 2008; 133(3): 677 - 683.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. L. Douglas, G. N. Bowman, H. A. Baghdoyan, and R. Lydic
C57BL/6J and B6.V-LEPOB mice differ in the cholinergic modulation of sleep and breathing
J Appl Physiol, March 1, 2005; 98(3): 918 - 929.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. J. Gottlieb, A. L. DeStefano, D. J. Foley, E. Mignot, S. Redline, R. J. Givelber, and T. Young
APOE {epsilon}4 is associated with obstructive sleep apnea/hypopnea: The Sleep Heart Health Study
Neurology, August 24, 2004; 63(4): 664 - 668.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. Hedner, H. Kraiczi, Y. Peker, and P. Murphy
Reduction of Sleep-disordered Breathing after Physostigmine
Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1246 - 1251.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.